Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Roach, Nancy Zhang, Ellie Corigliano, M. Jansson, Grant Toland, G. Ponto, M. Dolled-Filhart, K. Emancipator, D. Stanforth, K. Kulangara (2016)
Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung CancerApplied Immunohistochemistry & Molecular Morphology, 24
Therese Phillips, P. Simmons, H. Inzunza, J. Cogswell, J. Novotny, C. Taylor, Xiaoling Zhang (2015)
Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung CancerApplied Immunohistochemistry & Molecular Morphology, 23
Tian (2015)
Contribution of ultrasound-guided fine-needle aspiration cell blocks of metastatic supraclavicular lymph nodes to the diagnosis of lung cancerJ Cancer Res Ther, 11 Suppl
S. Kitazono, Y. Fujiwara, K. Tsuta, H. Utsumi, S. Kanda, H. Horinouchi, H. Nokihara, N. Yamamoto, S. Sasada, Shun-ichi Watanabe, H. Asamura, T. Tamura, Y. Ohe (2015)
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.Clinical lung cancer, 16 5
B. Skov, E. Høgdall, P. Clementsen, M. Krasnik, K. Larsen, J. Sørensen, T. Skov, A. Mellemgaard (2015)
The prevalence of EGFR mutations in non‐small cell lung cancer in an unselected Caucasian populationAPMIS, 123
J. Pyo, G. Kang, Jung Kim (2016)
Prognostic Role of PD-L1 in Malignant Solid Tumors: A Meta-AnalysisThe International Journal of Biological Markers, 32
R. Herbst, P. Baas, Dong-Wan Kim, E. Felip, J. Pérez-Gracia, Ji-Youn Han, J. Molina, Joo‐Hang Kim, C. Arvis, M. Ahn, M. Majem, M. Fidler, G. Castro, M. Garrido, G. Lubiniecki, Shentu Yue, E. Im, M. Dolled-Filhart, E. Garon (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trialThe Lancet, 387
M. Reck, D. Rodríguez-Abreu, A. Robinson, R. Hui, T. Csőszi, A. Fülöp, M. Gottfried, N. Peled, A. Tafreshi, S. Cuffe, M. O'Brien, Suman Rao, K. Hotta, M. Leiby, G. Lubiniecki, Shentu Yue, Reshma Rangwala, J. Brahmer (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.The New England journal of medicine, 375 19
C. Casadio, J. Guarize, S. Donghi, Clementina Tonno, C. Fumagalli, D. Vacirca, P. Dell'Orto, F. Marinis, L. Spaggiari, G. Viale, M. Barberis (2015)
Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.American journal of clinical pathology, 144 4
M. Ilié, V. Hofman, M. Dietel, J. Soria, P. Hofman (2016)
Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patientsVirchows Archiv, 468
N. Navani, M. Nankivell, D. Lawrence, S. Lock, H. Makker, D. Baldwin, R. Stephens, M. Parmar, S. Spiro, S. Morris, S. Janes (2015)
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trialThe Lancet. Respiratory Medicine, 3
R. José, P. Shaw, Magali Taylor, David Lawrence, P. George, S. Janes, N. Navani (2014)
Impact of EBUS-TBNA on modalities for tissue acquisition in patients with lung cancer.QJM : monthly journal of the Association of Physicians, 107 3
Jeyabalan (2016)
Adequacy of endobronchial ultrasound-guided transbronchial needle aspiration samples processed as histopathological samples for genetic mutation analysis in lung adenocarcinomaMol Clin Oncol, 4
F. Hirsch, A. McElhinny, D. Stanforth, J. Ranger-Moore, M. Jansson, K. Kulangara, William Richardson, P. Towne, D. Hanks, B. Vennapusa, A. Mistry, R. Kalamegham, S. Averbuch, J. Novotny, E. Rubin, K. Emancipator, I. McCaffery, A. Williams, Jill Walker, J. Longshore, M. Tsao, K. Kerr (2017)
PD‐L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD‐L1 IHC Assay Comparison ProjectJournal of Thoracic Oncology, 12
Swati Khanna, Anish Thomas, D. Abate-Daga, Jingli Zhang, B. Morrow, S. Steinberg, A. Orlandi, P. Ferroni, J. Schlom, F. Guadagni, R. Hassan (2016)
Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD‐L1 and the PD‐L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD‐L1 Antibody AvelumabJournal of Thoracic Oncology, 11
W. Travis, E. Brambilla, A. Nicholson, Y. Yatabe, J. Austin, M. Beasley, L. Chirieac, S. Dacic, E. Duhig, D. Flieder, K. Geisinger, F. Hirsch, Y. Ishikawa, K. Kerr, M. Noguchi, G. Pelosi, C. Powell, M. Tsao, I. Wistuba (2015)
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 10 9
A. Scheel, M. Dietel, L. Heukamp, K. Jöhrens, T. Kirchner, S. Reu, J. Rüschoff, H. Schildhaus, P. Schirmacher, M. Tiemann, A. Warth, W. Weichert, R. Fischer, J. Wolf, R. Buettner (2016)
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomasModern Pathology, 29
M. Ilié, E. Long-Mira, C. Bence, C. Butori, S. Lassalle, L. Bouhlel, L. Fazzalari, K. Zahaf, S. Lalvée, Kevin Washetine, J. Mouroux, N. Vénissac, M. Poudenx, J. Otto, J. Sabourin, C. Marquette, V. Hofman, P. Hofman (2016)
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.Annals of oncology : official journal of the European Society for Medical Oncology, 27 1
H. Borghaei, L. Paz-Ares, L. Horn, D. Spigel, M. Steins, N. Ready, L. Chow, E. Vokes, E. Felip, E. Holgado, F. Barlesi, M. Kohlhäufl, O. Arrieta, M. Burgio, J. Fayette, H. Léna, E. Poddubskaya, D. Gerber, S. Gettinger, C. Rudin, N. Rizvi, L. Crinò, G. Blumenschein, S. Antonia, C. Dorange, C. Harbison, F. Finckenstein, J. Brahmer (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.The New England journal of medicine, 373 17
E. Garon, N. Rizvi, R. Hui, N. Leighl, A. Balmanoukian, J. Eder, A. Patnaik, C. Aggarwal, M. Gubens, L. Horn, E. Carcereny, M. Ahn, E. Felip, Jong-Seok Lee, M. Hellmann, O. Hamid, J. Goldman, J. Soria, M. Dolled-Filhart, R. Rutledge, Jin Zhang, J. Lunceford, Reshma Rangwala, G. Lubiniecki, C. Roach, K. Emancipator, L. Gandhi (2015)
Pembrolizumab for the treatment of non-small-cell lung cancer.The New England journal of medicine, 372 21
Ratcliff (2017)
Agreement between programmed cell death ligand-1 diagnostic assays across multiple protein expression cut-offs in non-small cell lung cancerClin Cancer Res
P. Vilmann, P. Clementsen, S. Colella, M. Siemsen, P. Leyn, J. Dumonceau, F. Herth, A. Larghi, E. Vazquez-Sequeiros, C. Hassan, L. Crombag, D. Korevaar, L. Konge, J. Annema (2015)
Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS)Endoscopy, 47
Laura Bratton, Donna Russell, Qiang Yong, Loralee McMahon, Zhongren Zhou (2016)
Comparison of PD-L1 Immunostaining for Non-small Cell Carcinoma of the Lung Between Paired Cytological and Surgical SpecimensJournal of the American Society of Cytopathology, 5
Supplemental Digital Content is available in the text.
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Aug 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.